SINGLE-USE BIOREACTOR MARKET ANALYSIS

Single-Use Bioreactor Market, By Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, and Recombinant Proteins), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations, Academic & Research Institutes, and Other End Users), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

On March 28, 2024, Getinge, a medtech company has expanded its bioreactor portfolio with larger single-use systems. Getinge introduces the Single-Use Production Reactor (SUPR) system, initially available in 50-liter and 250-liter sizes.
In June 2022, mAbxience, a biotechnology company, enhanced its cGMP (Current Good Manufacturing Practice) facility in León, Spain by installing an additional ABEC 4,000L CSR bioreactor, following the successful delivery of the first 4,000L CSR bioreactor in 2021. mAbxience opted for ABEC's single-use technology to expand its CDMO (contract development and manufacturing organization) business and capacity.
In May 2022, RD-Biotech, a Contract Research Organization (CRO) specializing in plasmid DNA (pDNA) production for early-phase clinical trials, collaborated with Pall Corporation, global provider in high-tech filtration, separation to provide single-use solutions and purification technology to facilitate the manufacturing of industrially relevant volumes of GMP-grade pDNA.
In April 2020, Celltainer Biotech BV, a life science equipment company, announced intentions to collaborate with PAN-Biotech, manufactures and supplies a wide range of high quality reagents for use in cell culture as part of a strategic alliance aimed at providing comprehensive solutions for cell culture processes.